Discipline | Urology, oncology |
---|---|
Language | English |
Edited by | Stephen Freedland |
Publication details | |
History | 1997-present |
Publisher | |
Frequency | Quarterly |
5.554 (2020) | |
Standard abbreviations | |
ISO 4 | Prostate Cancer Prostatic Dis. |
Indexing | |
ISSN | 1365-7852 (print) 1476-5608 (web) |
Links | |
Prostate Cancer and Prostatic Diseases is a quarterly peer-reviewed medical journal covering all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management. Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and prostatitis. It was established in 1997 with Roger Kirby as the founding editor, [1] with Judd Moul becoming co-editor alongside Kirby in 2003. [2] It is published by Springer Nature Publishing Group. The outgoing editor-in-chief is Stephen J. Freedland (Cedars-Sinai Medical Center) and will be replaced by Cosimo De Nunzio (Sapienza University of Rome) from 1 January 2022. According to the Journal Citation Reports , the journal has a 2020 impact factor of 5.554, ranking it 16th out of 90 journals in the category "Urology & Nephrology" and 77th out of 242 journals in the category "Oncology". [3]
Urology, also known as genitourinary surgery, is the branch of medicine that focuses on surgical and medical diseases of the urinary-tract system and the reproductive organs. Organs under the domain of urology include the kidneys, adrenal glands, ureters, urinary bladder, urethra, and the male reproductive organs.
Cancer of the prostate is the second most common cancerous tumor worldwide and is the fifth leading cause of cancer-related mortality among men. The prostate is a gland in the male reproductive system that surrounds the urethra just below the bladder. It is located in the hypogastric region of the abdomen. To give an idea of where it is located, the bladder is superior to the prostate gland as shown in the image The rectum is posterior in perspective to the prostate gland and the ischial tuberosity of the pelvic bone is inferior. Most prostate cancers are slow growing. Cancerous cells may spread to other areas of the body, particularly the bones and lymph nodes. It may initially cause no symptoms. In later stages, symptoms include pain or difficulty urinating, blood in the urine, or pain in the pelvis or back. Benign prostatic hyperplasia may produce similar symptoms. Other late symptoms include fatigue, due to low levels of red blood cells.
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland.
BJU International is a monthly peer-reviewed medical journal that was established in 1929. The editor-in-chief is Freddie Hamdy and the journal is published by Wiley-Blackwell. It covers research on all aspects of urology.
Nature Reviews Urology is a monthly peer-reviewed medical journal published by Nature Portfolio. It covers all aspects of urology. The journal was established in 2004 as Nature Clinical Practice Urology and obtained its current title in April 2009. The editor-in-chief is Annette Fenner.
Nature Reviews Nephrology is a monthly peer-reviewed review journal published by Nature Portfolio. It was established as Nature Clinical Practice Nephrology in 2005, but change name in 2009. The editor-in-chief is Susan Allison.
Prostatectomy is the surgical removal of all or part of the prostate gland. This operation is done for benign conditions that cause urinary retention, as well as for prostate cancer and for other cancers of the pelvis.
Urologic diseases or conditions include urinary tract infections, kidney stones, bladder control problems, and prostate problems, among others. Some urologic conditions do not affect a person for that long and some are lifetime conditions. Kidney diseases are normally investigated and treated by nephrologists, while the specialty of urology deals with problems in the other organs. Gynecologists may deal with problems of incontinence in women.
Amin J. Barakat is a Lebanese-American physician known for the diagnosis Barakat syndrome.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.
The Journal of Sexual Medicine (JSM) is a peer-reviewed medical journal published on behalf of the International Society for Sexual Medicine. Besides the latter society, it is also an official journal for the International Society for the Study of Women's Sexual Health. The editor-in-chief is John P. Mulhall. The related open access journal, Sexual Medicine, was launched in 2013.
Dr. Michael A. Palese, is an American urologist specializing in robotic, laparoscopic and endoscopic surgery, with a special emphasis on robotic surgeries relating to kidney cancer and kidney stone disease.
Roger Sinclair Kirby FRCS(Urol), FEBU is a British retired prostate surgeon and professor of urology, researcher, writer on men's health and prostate disease, founding editor of the journal Prostate Cancer and Prostatic Diseases and Trends in Urology and Men's Health and a fundraiser for prostate disease charities, best known for his use of the da Vinci surgical robot for laparoscopic prostatectomy in the treatment of prostate cancer. He is a co-founder and president of the charity The Urology Foundation (TUF), vice-president of the charity Prostate Cancer UK, trustee of the King Edward VII's Hospital and as of 2020 is president of the Royal Society of Medicine (RSM), London.
Prokar Dasgupta FRCS(Urol), FEBU is an Indian-born British surgeon and academic who is professor of surgery at the surgical academy at King's Health Partners, London, UK. Since 2002, he has been consultant urologist to Guy's Hospital, and in 2009 became the first professor of robotic surgery and urology at King's, and subsequently the chairman of the King's College-Vattikuti Institute of Robotic Surgery.
John M. Fitzpatrick was an Irish urologist, emeritus professor of surgery at the University College Dublin School of Medicine & Medical Science and Head of Research at the Irish Cancer Society.
IJIR: Your Sexual Medicine Journal is a bimonthly peer-reviewed medical journal covering the study of sexual dysfunction. It was established in 1989 and is published by Springer Nature. The editor-in-chief is Ege Can Serefoglu. According to the Journal Citation Reports, the journal has a 2021 impact factor of 2.408, ranking it 43rd out of 90 journals in the category "Urology and Nephrology".
The Clinical Journal of the American Society of Nephrology is a monthly peer-reviewed medical journal covering nephrology. It was established in 2006 and is published by the American Society of Nephrology. The editor-in-chief is Rajnish Mehrotra. According to the Journal Citation Reports, the journal has a 2020 impact factor of 8.237, ranking it 4th out of 80 journals in the category "Urology & Nephrology".
The Urology Foundation (TUF) is a charity that works across the UK and Ireland with the aim of improving the knowledge and skills of surgeons who operate on diseases of the male and female urinary-tract system and the male reproductive organs and funds research to improve outcomes of all urological conditions and urological cancers.
Dr. Alan Wayne Partin was an American prostate surgeon and researcher. He was the Jakurski Family Director of the Brady Urological Institute, Urologist-In-Chief of Johns Hopkins School of Medicine, and professor of Urology, Pathology, and Oncology. In 1993, he developed the PartinTables to help prostate cancer patients get an accurate prediction of their likelihood of being cured.